Nystatin and Saccharomyces boulardii drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nystatin and Saccharomyces boulardii. Common interactions include breast cancer among females and back pain among males.

The phase IV clinical study analyzes what interactions people who take Nystatin and Saccharomyces boulardii have. It is created by eHealthMe based on reports of 26 people who take Nystatin and Saccharomyces boulardii from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

26 people who take Nystatin and Saccharomyces boulardii together, and have interactions are studied.

What is Nystatin?

Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 29,027 Nystatin users for its effectiveness, alternative drugs and more.

What is Saccharomyces boulardii?

Saccharomyces boulardii has active ingredients of saccharomyces boulardii. eHealthMe is studying from 747 Saccharomyces boulardii users for its effectiveness, alternative drugs and more.

Number of Nystatin and Saccharomyces boulardii reports submitted per year:

Common Nystatin and Saccharomyces Boulardii drug interactions by gender *:

female:

Breast cancer
Cataract
Colitis
Constipation
Facial paralysis
Gastrointestinal disorder
Hepatic cirrhosis
Hepatic encephalopathy
Intestinal obstruction
Neuropathy peripheral

male:

Back pain
Tumour lysis syndrome
Brain injury
Bursitis
Clostridium difficile colitis
Confusional state
Conjunctival haemorrhage
Conjunctivitis
Dehydration
Device related infection

Common Nystatin and Saccharomyces Boulardii drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Brain injury
Confusional state
Depression
Disorientation
Disturbance in attention
Dizziness
Dyspnoea
Fear
Headache
Palpitations

30-39:

n/a

40-49:

Facial paralysis
Gastrointestinal disorder
Hepatic cirrhosis
Hepatic encephalopathy
Neuropathy peripheral
Pleural effusion
Muscle spasms
Breast cancer
Cardiac failure congestive
Cataract

50-59:

Colitis
Intestinal obstruction
Colitis ischaemic

60+:

Back pain
Diarrhoea
Dehydration
Device related infection
Diabetes mellitus
Fluid retention
Flushing
Fungal infection
Headache
Hyperlipidaemia

Common conditions people have *:

Pain: 9 people, 34.62%
Immunodeficiency Common Variable: 6 people, 23.08%
Thrombocytopenia (decrease of platelets in blood): 4 people, 15.38%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 4 people, 15.38%
Septic Shock (shock due to blood infection): 4 people, 15.38%
Sepsis (a severe blood infection that can lead to organ failure and death): 4 people, 15.38%
High Blood Pressure: 3 people, 11.54%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 11.54%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 7.69%
Oropharyngeal Candidiasis (fungal infection of oropharynx): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nystatin and Saccharomyces boulardii?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Nystatin (29,027 reports)
Saccharomyces boulardii (747 reports)